Ericsson, Nokia combine on research for 6G video
Ericsson and Nokia Collaborate on 6G Video Research Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of-concept for a technology designed to address 6G v…
Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…
Vesper Solar 600 MW Texas project shows how an agrivoltaics mindset can unlock prime sites
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
New ‘Pay One, Stay Two’ parking deal to boost Waverley town centres
New Parking Initiative to Boost Waverley Town Centres Waverley Borough Council is trialing a new parking scheme, "Pay One, Stay Two", to e…
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company…
This ‘minor’ bird flu strain has potential to spark human pandemic
Bird Flu Strain H9N2: A Potential Threat to Humans A team of scientists has raised concerns about the H9N2 bird flu virus, which has adapt…
Older Patients and Women Bear the Brunt of CTD-ILD Burden
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…
Trump rules out vice presidential run to stay in power after 2028 - Jamaica Observer
Trump Rejects Vice Presidential Run Donald Trump has ruled out running for vice president in the 2028 American election. Aboard Air…
Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…
Do the Warriors have enough to maximize Stephen Curry’s remaining years?
Can the Warriors Maximize Stephen Curry's Remaining Years? Stephen Curry remains an exceptional player, and his supporting cast has improv…
South Africa: SAHPRA Approves Lenacapavir for HIV Prevention
South Africa Approves Lenacapavir for HIV Prevention South Africa's Health Product Regulatory Authority (SAHPRA) has approved lenacapavir,…